Fidelity Dumps Valeant Shares In Thick Of Allergan Assault
In the increasingly acrimonious buyout fight between Allergan Inc. and Valeant Pharmaceuticals International Inc., Allergan appears to have convinced at least one big fund manager to ditch nearly three-quarters of his...To view the full article, register now.
Already a subscriber? Click here to view full article